Author: kgrayson

Cells in the body are all supported within a network of fibers made of collagen called the extracellular matrix. This matrix is what gives tissues their shape. As a more plain example, picture a steak. The muscle cells alone can’t

It is well known that metastatic cancer causes the vast majority of deaths as opposed to the original tumor. However, researchers still struggle to fully understand the mechanisms of metastasis due to a lack of tools that can probe the

Dr. Sasha Mendjan’s research team at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences has recently developed heart organoids, called “cardioids”, which may revolutionize research within congenital heart and cardiovascular disorders. They utilized a naturally-occurring process known

One of the most common types of brain tumors are metastases (secondary tumors that come from cancer in another part of the body). Typically, patients affected by brain metastases have a very poor survival rate. Some people benefit from immunotherapy

     Dr. Steinmetz et al. at the Centre for Genomic Regulation and the European Molecular Biology Laboratory have produced a new single-cell transcription method, MutaSeq, that identifies healthy stem cells versus cancer stem cells.  Tissues such as the intestinal

A recent study from the National University of Singapore has shown that the protein encoding gene KMT5A, along with a handful of other genes, enables neural stem cells (NSCs) to switch between quiescence and proliferation. This process is essential for

Recent studies at the Sydney Kimmel Cancer-Jefferson Health (SKCC) have shown that the circadian clock gene (CRY1) promotes tumor progression by altering DNA repair. The “circadian clock” in question is how our bodies’ processes synchronize with the day/night cycle and

As it turns out, cancer cells are all capable of slowing down and entering a hibernation-like state known as “diapause”. In this status, they are able to survive chemotherapy and build up a resistance to the drugs. They work as

Researchers at the University of North Carolina have recently discovered that activating an immune signaling pathway called STING can enhance the ability of genetically engineered T cells (CAR T cells) to eradicate breast cancer in mice. Originally, CAR T cells

Dr. Kazukani Hayashi’s research team at Cedars-Sinai has recently shown that taking both Gemcitabine (a chemotherapy drug) and Celebrex (an anti-inflammatory drug) together triggers an immune response that increases the efficacy of the chemotherapy drug. Said drug is primarily used